Filing Details
- Accession Number:
- 0001181431-12-064463
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-12-13 16:28:01
- Reporting Period:
- 2012-11-27
- Filing Date:
- 2012-12-13
- Accepted Time:
- 2012-12-13 16:28:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1202294 | Elliot Sigal | Bristol-Myers Squibb Company 345 Park Avenue New York NY 10154 | Evp, Cso & President R&D | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.10 Par Value | Disposition | 2012-11-27 | 200,630 | $0.00 | 50,158 | No | 5 | G | Indirect | By Sigal Family Investments, LLC |
Common Stock, $0.10 Par Value | Acquisiton | 2012-11-27 | 100,315 | $0.00 | 100,315 | No | 5 | G | Indirect | By C. Elliott Sigal 2012 Irrevocable Trust |
Common Stock, $0.10 Par Value | Acquisiton | 2012-11-27 | 100,315 | $0.00 | 100,315 | No | 5 | G | Indirect | By Ruth L. Sigal 2012 Irrevocable Trust |
Common Stock, $0.10 Par Value | Disposition | 2012-12-11 | 31,451 | $33.00 | 18,707 | No | 4 | S | Indirect | By Sigal Family Investments, LLC |
Common Stock, $0.10 Par Value | Disposition | 2012-12-11 | 62,903 | $33.00 | 37,412 | No | 4 | S | Indirect | By C. Elliott Sigal 2012 Irrevocable Trust |
Common Stock, $0.10 Par Value | Disposition | 2012-12-11 | 62,903 | $33.00 | 37,412 | No | 4 | S | Indirect | By Ruth L. Sigal 2012 Irrevocable Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | G | Indirect | By Sigal Family Investments, LLC |
No | 5 | G | Indirect | By C. Elliott Sigal 2012 Irrevocable Trust |
No | 5 | G | Indirect | By Ruth L. Sigal 2012 Irrevocable Trust |
No | 4 | S | Indirect | By Sigal Family Investments, LLC |
No | 4 | S | Indirect | By C. Elliott Sigal 2012 Irrevocable Trust |
No | 4 | S | Indirect | By Ruth L. Sigal 2012 Irrevocable Trust |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, $0.10 Par Value | 48,052 | Direct | |
Common Stock, $0.10 Par Value | 1,600 | Indirect | By BMY Savings and Investment Program |
Footnotes
- On September 6, 2012, in a transaction exempt from Section 16 (including the reporting requirements) by virtue of Rule 16a-13, the reporting person and his wife contributed their combined interest in 250,788 directly-owned shares to Sigal Family Investments, LLC ("SFI") in exchange for interests in SFI. Following the transaction, the reporting person had direct ownership of 48,052 shares and indirect ownership, together with his wife, of 250,788 shares through SFI. As of September 6, 2012, the reporting person held a 60% interest in SFI and the reporting person's wife held a 40% interest in SFI. The reporting person is the sole manager of SFI.
- On November 27, 2012, the reporting person contributed a 40% interest in SFI to the C. Elliott Sigal 2012 Irrevocable Trust for the benefit of the reporting person's wife and their children. The reporting person's wife serves as a co-trustee. The reporting person retains a 20% interest in SFI.
- On November 27, 2012, the reporting person's wife contributed her 40% interest in SFI to the Ruth L. Sigal 2012 Irrevocable Trust for the benefit of the reporting person and their children.
- The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purpose.
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $32.81 to $33.23, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Based on a plan statement as of the end of the most recent fiscal quarter.